Microsoft (MSFT) Holder Boussard & Gavaudan Investment Management Llp Lowered Its Holding; As Chemocentryx (CCXI) Market Valuation Rose, Holder P-A-W Capital Trimmed by $400,000 Its Stake

Microsoft Corporation (NASDAQ:MSFT) Logo

P-A-W Capital Corp decreased its stake in Chemocentryx Inc (CCXI) by 44.44% based on its latest 2018Q4 regulatory filing with the SEC. P-A-W Capital Corp sold 40,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 50,000 shares of the health care company at the end of 2018Q4, valued at $546,000, down from 90,000 at the end of the previous reported quarter. P-A-W Capital Corp who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $730.19 million market cap company. The stock increased 4.36% or $0.58 during the last trading session, reaching $13.89. About 458,813 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since March 31, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/03/2018 ChemoCentryx 4Q EPS 80c; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA

Boussard & Gavaudan Investment Management Llp decreased its stake in Microsoft Corp (MSFT) by 77.7% based on its latest 2018Q4 regulatory filing with the SEC. Boussard & Gavaudan Investment Management Llp sold 200,262 shares as the company’s stock rose 1.03% with the market. The institutional investor held 57,461 shares of the prepackaged software company at the end of 2018Q4, valued at $5.77 million, down from 257,723 at the end of the previous reported quarter. Boussard & Gavaudan Investment Management Llp who had been investing in Microsoft Corp for a number of months, seems to be less bullish one the $904.86 billion market cap company. The stock increased 0.86% or $1.01 during the last trading session, reaching $117.94. About 25.40 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 20.90% since March 31, 2018 and is uptrending. It has outperformed by 16.53% the S&P500. Some Historical MSFT News: 02/04/2018 – Kenna Security Given 5-Star Rating in CRN’s 2018 Partner Program Guide; 17/05/2018 – Microsoft Pitches Greener Cloud to Win Clients From Own Servers; 02/05/2018 – DELL, MICROSOFT PARTNER TO OFFER IOT SOLUTIONS FOR BUSINESSES; 03/04/2018 – Electric Imp and Microsoft Partner to Accelerate Secure IoT and Simplify Connectivity for Industrial and Commercial Customers; 26/04/2018 – MICROSOFT CFO HOOD COMMENTS ON CAPEX SPENDING IN INTERVIEW; 26/04/2018 – MSFT Filings: Microsoft Corp 8-K Filed On 2018-04-26; 12/03/2018 – Loan Processing Made Easy: Conduent Introduces Simplified Consumer Finance Platform; 23/05/2018 – Eyecarrot Announces Shipment of its First 50 Binovi Touch Saccadic Fixator Units; 07/03/2018 – Nintendo saw its share of the games console market rise, while Microsoft’s share declined; 15/03/2018 – Google, Amazon and Microsoft cloud businesses helped more than double spending on data centers last year 2018 could be a record, too

Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on April, 25. They expect $1.00 EPS, up 5.26% or $0.05 from last year’s $0.95 per share. MSFT’s profit will be $7.67B for 29.49 P/E if the $1.00 EPS becomes a reality. After $1.10 actual EPS reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts -9.09% negative EPS growth.

Since October 26, 2018, it had 0 insider purchases, and 8 sales for $58.46 million activity. The insider Capossela Christopher C sold $432,000. The insider Nadella Satya sold $28.35 million. Hogan Kathleen T sold 36,500 shares worth $4.06M.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Seekingalpha.com which released: “Microsoft brings PC games to Xbox – Seeking Alpha” on March 13, 2019, also Nasdaq.com with their article: “After Hours Most Active for Mar 11, 2019 : AMD, FB, MSFT, XOG, UAL, SFIX – Nasdaq” published on March 11, 2019, Nasdaq.com published: “Technology Sector Update for 03/21/2019: SPI, CSIQ, MU, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” on March 21, 2019. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Nasdaq.com and their article: “Technology Sector Update for 03/08/2019: DCAR, UPLD, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” published on March 08, 2019 as well as Nasdaq.com‘s news article titled: “Technology Sector Update for 03/07/2019: CTK, SSYS, GWRE, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” with publication date: March 07, 2019.

Investors sentiment increased to 0.94 in 2018 Q4. Its up 0.13, from 0.81 in 2018Q3. It improved, as 55 investors sold MSFT shares while 925 reduced holdings. 168 funds opened positions while 758 raised stakes. 5.48 billion shares or 3.82% more from 5.28 billion shares in 2018Q3 were reported. Aspen Investment Mgmt invested 2.17% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Acropolis Invest Mgmt Llc has invested 0.61% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). 389 were reported by Ogorek Anthony Joseph Adv. Selway Asset Mgmt holds 2.44% in Microsoft Corporation (NASDAQ:MSFT) or 32,625 shares. Putnam Fl Invest owns 3.94% invested in Microsoft Corporation (NASDAQ:MSFT) for 356,755 shares. Morgens Waterfall Vintiadis holds 59,180 shares. Rhumbline Advisers holds 12.90 million shares or 2.85% of its portfolio. Cibc Asset Mngmt holds 1.31M shares. Bryn Mawr has invested 2.54% in Microsoft Corporation (NASDAQ:MSFT). Stillwater Cap Ltd Limited Liability Company reported 4.48% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Invesco Limited has invested 3.15% in Microsoft Corporation (NASDAQ:MSFT). Aspiriant Lc accumulated 53,044 shares. Pinnacle Assocs Limited reported 626,060 shares. Santa Barbara Asset Ltd accumulated 3.13 million shares. 90,100 are held by Sensato Invsts Lc.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Benzinga.com which released: “Cancer Biology Clinical Research Seeking Answers at Cellular Level – Benzinga” on March 26, 2019, also Benzinga.com with their article: “10 Biggest Price Target Changes For Wednesday – Benzinga” published on March 27, 2019, Globenewswire.com published: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” on March 28, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Nasdaq.com and their article: “ChemoCentryx (CCXI) Looks Good: Stock Adds 5.5% in Session – Nasdaq” published on March 19, 2019 as well as Benzinga.com‘s news article titled: “71 Biggest Movers From Yesterday – Benzinga” with publication date: March 28, 2019.

Since October 16, 2018, it had 0 buys, and 8 insider sales for $87.64 million activity. Another trade for 7.34M shares valued at $85.85M was made by GLAXOSMITHKLINE PLC on Tuesday, October 16. Cappel Markus J. also sold $74,079 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares. $457,747 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares were sold by KANAYA SUSAN M.

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart

http://endigest.com/
http://endigest.com/http://endigest.com/

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *